Monday, December 3, 2018

Ready to evaluate structures and transactions to assuage investor concerns: Sun Pharma

Ready to evaluate structures and transactions to assuage investor concerns: Sun Pharma "As of now, the company has not received any query from SEBI with regards to whistleblower complaint, Sun Pharma founder and MD Dilip Shanghvi said.

from Moneycontrol Business News https://ift.tt/2DVsfeK

No comments:

Post a Comment

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...